AKTIEB. ELECTROLUX B ADR SPNSD
ELUX
ELUX was delisted on the 31st of March, 2005.
6 hedge funds and large institutions have $10.2M invested in AKTIEB. ELECTROLUX B ADR SPNSD in 2017 Q3 according to their latest regulatory filings, with funds opening new positions, 2 increasing their positions, 2 reducing their positions, and closing their positions.
13% more capital invested
Capital invested by funds: $9.04M → $10.2M (+$1.17M)
0% more funds holding
Funds holding: 6 → 6 (0)
0% more repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
+$831K |
| 2 |
GT
Glenmede Trust
Philadelphia,
Pennsylvania
|
+$46.9K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GIM
Granahan Investment Management
Waltham,
Massachusetts
|
-$6.13K |
| 2 |
WAM
World Asset Management
Detroit,
Michigan
|
-$1.56K |
ELUX Hedge Fund Activity: Q3 2017 in Review
6 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in AKTIEB. ELECTROLUX B ADR SPNSD (ELUX) for Q3 2017, worth a combined $10.2M — up 13% from $9.04M a quarter earlier.
Fund positioning in ELUX was balanced in Q3 2017: 0 funds opened new positions, 0 closed out, 2 added to existing stakes and 2 trimmed.
The largest buyer was Parametric Portfolio Associates, adding an estimated $831K. The largest seller was Granahan Investment Management, cutting an estimated $6.13K.
- 6 institutional investors held AKTIEB. ELECTROLUX B ADR SPNSD (ELUX) as of Q3 2017, unchanged from Q2 2017.
- Funds reported $10.2M of AKTIEB. ELECTROLUX B ADR SPNSD stock for Q3 2017, up 13% quarter-over-quarter.
- 0 funds opened new AKTIEB. ELECTROLUX B ADR SPNSD positions in Q3 2017 and 0 closed out.
- The largest AKTIEB. ELECTROLUX B ADR SPNSD buyer in Q3 2017 was Parametric Portfolio Associates, an estimated $831K added.
- The largest AKTIEB. ELECTROLUX B ADR SPNSD seller in Q3 2017 was Granahan Investment Management, an estimated $6.13K sold.
Based on aggregated 13F filings for Q3 2017.